Trump Executive Order Tracker | Akin Public Policy and Lobbying

Regulatory Relief to Promote Domestic Production of Critical Medicines (Trump EO Tracker)

May 5, 2025

Reading Time : 1 min
Trump Executive Order Tracker | Akin Public Policy and Lobbying

This order streamlines the regulation of manufacturing pharmaceutical products and inputs to facilitate the restoration of a robust domestic pharmaceutical manufacturing base.

Within 180 days, the order directs the Secretary of Health and Human Services, through the FDA Commissioner, to review existing regulations and guidance that pertain to the development of domestic pharmaceutical manufacturing and take steps to eliminate any duplicative or unnecessary requirements in such regulations and guidance; maximize the timeliness and predictability of agency review; and streamline and accelerate the development of domestic pharmaceutical manufacturing.

Within 90 days of the order, the FDA Commissioner is directed to develop and advance improvements to the risk-based inspection regime that ensures routine reviews of overseas manufacturing facilities involved in the supply of United States medicines, funded by increased fees on foreign manufacturing facilities and the FDA Commissioner must publicly disclose the annual number of inspections that the FDA conducts on such foreign facilities.

Within 180 days, the order instructs the Administrator of the Environmental Protection Agency (EPA) to take action to update regulations and guidance that apply to the inspection and approval of new and expanded manufacturing capacity of pharmaceutical products, active pharmaceutical ingredients, key starting materials, and associated raw materials in the United States to eliminate any duplicative or unnecessary requirements and maximize the timeliness and predictability of agency review.

Within 180 days of the order, the Secretary of the Army, acting through the Assistant Secretary of the Army for Civil Works, shall review the nationwide permits issued under section 404 of the Clean Water Act of 1972 (33 U.S.C. 1344) and section 10 of the Rivers and Harbors Appropriation Act of 1899 (33 U.S.C. 403) to determine whether an activity-specific nationwide permit is needed to facilitate the efficient permitting of pharmaceutical manufacturing facilities.

Additional Documentation

Share This Insight

Related Content

Trump Executive Order Tracker

The significant number of executive orders published by the Trump Administration cut across dozens of industries and areas of law. This searchable tool breaks down the orders and their impacts on specific industries and with in-depth analysis of specific orders.

Previous Entries

Trump Executive Order Tracker

March 26, 2026

Requires federal agencies to prohibit contractors and subcontractors from engaging in “racially discriminatory DEI activities” by mandating a new contract clause across federal procurement. Establishes enforcement mechanisms—including contract termination, suspension, debarment, and potential False Claims Act liability—and directs government-wide regulatory updates to embed these requirements into the Federal Acquisition Regulation (FAR).
 
The order requires agencies to incorporate the mandated contract clause within 30 days, directs the FAR Council to issue interim guidance within 60 days, and mandates agency compliance reports within 120 days. 

...

Read More

Trump Executive Order Tracker

March 24, 2026

Extends the Federal Emergency Management Agency (FEMA) Review Council through May 29, 2026, or until 10 days after submission of its final report, to allow additional time to complete and submit its final report assessing FEMA's operations and effectiveness.

...

Read More

Trump Executive Order Tracker

March 20, 2025

Directs federal agencies to preserve a dedicated national broadcast window for the Army-Navy Game by discouraging scheduling conflicts with College Football Playoff and other postseason games. Calls for coordination with collegiate athletics organizations and broadcasters, and directs the Federal Communications Commission (FCC) to assess whether the game should be treated as a public interest or national service event.   

...

Read More

Trump Executive Order Tracker

March 13, 2026

Amends prior presidential delegations under the Defense Production Act to allow the Secretary of Energy, alongside the Secretary of Commerce, to independently exercise certain authorities related to national defense resource preparedness. Clarifies that under Executive Order 14156, Declaring a National Energy Emergency, agency heads may act directly when authority has been delegated rather than seeking additional presidential approval.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.